Fellowship Awards

The Society for Immunotherapy of Cancer (SITC) is proud to announce the recipients of the SITC 2017 Cancer Immunotherapy Fellowship Awards. The fellowship award program was established through SITC’s Forward Fund to support the development of young investigators in the field in order to cultivate the next generation of cancer immunotherapy experts.

SITC would like to thank Genentech, Merck & Co., Inc. and the NCI Center for Cancer Research, who helped to make these awards possible.

2017 SITC-Merck Immunotherapy in Lung Cancer Clinical Fellowship Recipient

Ghosh.jpgArnab Ghosh, MD, PhD
Memorial Sloan-Kettering Cancer Center

AMOUNT: $100,000 for one year
"Enhancing antitumor immunity mediated by costimulatory agents through reprogramming myeloid infiltrating cells"

Sponsored by

Made possible by an educational grant from Merck & Co., Inc.

2017 SITC’s Holbrook Kohrt, MD, PhD Cancer Immunotherapy Translational Memorial Fellowship Recipient

Singh_photo_NEW.jpgNathan Singh, MD, MS
University of Pennsylvania

AMOUNT: $100,000 for one year
"Enhancing CAR T cell efficacy by disrupting immune inhibition"

Sponsored by

Made possible by an educational grant from Genentech.

2017 NCI Immunotherapy Fellowship Recipient

This award, co-sponsored by the National Cancer Institute (NCI) of the National Institutes of Health and SITC and made possible in part by a grant from EMD Serono, provides a young investigator with an opportunity to further their education and experience in the field of cancer immunotherapy.

This fellow will have exposure to multiple clinical immunotherapeutic approaches, and also to key opinion leaders in the field of clinical immunotherapy during this one year program at the CCR in Bethesda, MD.

Marciscano.jpgAriel E. Marciscano, MD
Johns Hopkins University